Cortexyme Inc at H C Wainwright Global Investment Conference (Virtual) Transcript

Sep 13, 2021 / 11:00AM GMT
Andrew S. Fein - H.C. Wainwright & Co, LLC, Research Division - MD of Equity Research & Senior Healthcare Analyst

Hello, everyone. I'm Andrew Fein. I'm one of the biotechnology analysts at H.C. Wainwright. It's my pleasure to introduce the next company presenting at the conference, which is Cortexyme. Presenting for the company will be its CEO and CFO, Casey Lynch and Chris Lowe, respectively.

So with that, Casey, I wanted to just take a couple of minutes to introduce yourself, introduce the company. And then from there, we can go into specific questions.

Casey C. Lynch - Cortexyme, Inc. - Co-Founder, Chairman, President & CEO

Yes. Great to be here, Andrew. I'm Casey Lynch, Co-Founder and CEO. I'm an entrepreneur with a background in Alzheimer's research. I've been very focused on understanding a comprehensive hypothesis of Alzheimer's disease throughout my career. So I'm very excited to be reaching a pivotal moment in milestones for Cortexyme. We're a few months away from a pivotal readout in a Phase III study in mild-to-moderate Alzheimer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot